We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Warning to Bristol-Myers Subsidiary
FDA Issues Warning to Bristol-Myers Subsidiary
June 2, 2005
Bristol-Myers Squibb subsidiary ConvaTec recently received an FDA warning letter for multiple violations of the agency’s quality system regulation (QSR) at ConvaTec’s manufacturing facility.